tm
Seeing Is Believing
tm
Seeing Is Believing
AVTE is currently covered by 3 analysts with an average price target of $7.96. This is a potential upside of $6.05 (316.75%) from yesterday's end of day stock price of $1.91.
Aerovate Therapeutics's activity chart (see below) currently has 2 price targets and 11 ratings on display. The stock rating distribution of AVTE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 52.08% with an average time for these price targets to be met of 62 days.
Highest price target for AVTE is $3, Lowest price target is $2, average price target is $7.96.
Most recent stock forecast was given by JULIAN HARRISON from BTIG on 17-Jun-2024. First documented stock forecast 26-Jul-2021.
Currently out of the existing stock ratings of AVTE, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$27
2 months 30 days ago
2/2 (100%)
$8.97 (49.75%)
90
Buy
$3
$1.1 (57.89%)
$54
2 months 30 days ago
1/3 (33.33%)
$1.35 (81.82%)
84
Buy
$2
$0.1 (5.26%)
$65
2 months 30 days ago
3/4 (75%)
$0.35 (21.21%)
74
Buy
$36
$22.43 (165.29%)
1 years 6 months 15 days ago
0/1 (0%)
$13.53 (60.21%)
What is AVTE (Aerovate Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AVTE (Aerovate Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AVTE (Aerovate Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AVTE (Aerovate Therapeutics)?
Which analyst is the currently most bullish on AVTE (Aerovate Therapeutics)?
Which analyst is the currently most reserved on AVTE (Aerovate Therapeutics)?
